1.Synchronous uterine and ovarian carcinoma: A diagnostic and therapeutic challenge.
Leonila A ESTOLE-CASANOVA ; Jericho Thaddeus P LUNA
Philippine Journal of Obstetrics and Gynecology 2007;31(2):107-113
Simultaneous development of carcinoma in the endometrium and ovary is a rare but well recognized phenomenon. Clinical impact of correctly diagnosing these tumors versus metastatic is significant and has important therapeutic and prognostic implications. Clinicopathologic criteria have been used to distinguish synchronous tumors from metastatic disease. In some cases, it may be difficult, if not impossible, to distinguish between metastatic and independent malignancy because the tumors may share features of both categories. Treatment strategies are, therefore, individualized and formulated. Such cases remain to be a diagnostic and therapeutic challenge. (Author)
Uterine Neoplasms
;
Ovarian Neoplasms
;
Serous Cyst Adenocarcinoma
;
Endometrioidadeno Carcinoma
2.Cystic Neoplasms of the Pancreas.
Gi Hun HONG ; Yang Won NAH ; Sung Woo HONG ; Hyucksang LEE
Journal of the Korean Surgical Society 1999;57(4):574-581
BACKGROUND: Cystic neoplasms of the pancreas are rare tumors that constitute about 10% of all cystic lesions of the pancreas and less than 1% of all pancreatic neoplasms. This study was conducted to investigate the diagnostic accuracy and postoperative results for these rare tumors. METHODS: The authors reviewed retrospectively 7 patients with cystic neoplasms of the pancreas who had been treated surgically in the period from 1986 through 1998 at the Department of Surgery, Paik Hospital, Seoul. RESULTS: There were 3 serous cystadenomas, 3 mucinous cystadenomas, and 1 papillary and cystic neoplasm. All 7 patients were women. The mean age of the patients was 36.7 years, 45 years for the serous tumors and 37 for the mucinous tumors. Two patient had diabetes mellitus. Major symptoms were abdominal pain (71%) and an abdominal mass (29%). One patient with a mucinous cystadenoma presented with bleeding from gastric varix which developed as a consequence of a splenic vein obstruction by the tumor. The positive rate for CEA was 33.3%, and that for CA 19-9 was 50.0%. No patient showed an abnormally elevated serum amylase level. Computed tomography was helpful in differentiating cystic tumors from pseudocysts or adenocarcinomas of the pancreas. The sites of the lesions were the tail in 3 cases, the body in 2cases, and the head in 2 cases. A distal pancreatectomy was performed in 5 cases, a pylorus-preserving pancreatoduodenectomy in 1 case, and enucleation of the cyst in 1 case. All the patients were alive at 3 to 145 months postoperatively and showed no evidence of disease. CONCLUSION: We conclude that the prognosis for resected cystic neoplasms of the pancreae is good. The correct preoperative differential diagnosis of pancreatic cystic lesions is important for planning the appropriate management, even though the clinical and the radiological features of these lesions are not always reliable.
Abdominal Pain
;
Adenocarcinoma
;
Amylases
;
Cystadenoma
;
Cystadenoma, Mucinous
;
Cystadenoma, Serous
;
Diabetes Mellitus
;
Diagnosis, Differential
;
Esophageal and Gastric Varices
;
Female
;
Head
;
Hemorrhage
;
Humans
;
Mucins
;
Pancreas*
;
Pancreatectomy
;
Pancreatic Cyst
;
Pancreatic Neoplasms
;
Pancreaticoduodenectomy
;
Prognosis
;
Retrospective Studies
;
Seoul
;
Splenic Vein
Result Analysis
Print
Save
E-mail